Evidence map›Paper›PMID 33785076›Full record

ArticleGenome medicine2021

The global dissemination of hospital clones of Enterococcus faecium.

Sebastiaan J van Hal, Rob J L Willems, Theodore Gouliouris, Susan A Ballard, Teresa M Coque, Anette M Hammerum, Kristin Hegstad, Hendrik T Westh, Benjamin P Howden, Surbhi Malhotra-Kumar and 7 more

Open access · goldAbstract read
In one paragraph

Article in Genome medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 1 synthesis or guideline pooled it, 72 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Antibiotics (Basel, Switzerland) · 2026
    Article
  7. Review
  8. Article
  9. Review
  10. Characterization ofVeterinary sciences · 2026
    Article
  11. Article
  12. Article
  13. Genomic Epidemiology of Vancomycin-ResistantAntibiotics (Basel, Switzerland) · 2025
    Article
  14. Microbial genomics · 2025
    Article
  15. Co-carriage of diverse vancomycin-resistantJAC-antimicrobial resistance · 2025
    Article
  16. Article
  17. Article
  18. Deciphering vancomycin resistance inFrontiers in microbiology · 2025
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 10 institutions in 10 countries.

Sebastiaan J van HalDepartment of Infectious Disesase and Microbiology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. Sebastiaan.vanhal@health.nsw.gov.au.ORCID 0000-0001-5852-4155
Rob J L WillemsDepartment of Medical Microbiology, University Medical Center Utrech, Utrecht, The Netherlands.
Theodore GouliourisCambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Susan A BallardMicrobiological Diagnostic Unit Public Health Laboratory, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
Teresa M CoqueDepartment of Microbiology, Ramón y Cajal University Hospital and Ramón y Cajal Health Research Institute (IRYCIS), Madrid, Spain.
Anette M HammerumStatens Serum Institut, 2300, Copenhagen S, Denmark.
Kristin HegstadDepartment of Microbiology and Infection Control, Norwegian National Advisory Unit on Detection of Antimicrobial Resistance, University Hospital of North-Norway, Tromsø, Norway.
Hendrik T WesthMRSA Knowledge Center, Department of Clinical Microbiology, Hvidovre Hospital, Hvidovre, Denmark.
Benjamin P HowdenMicrobiological Diagnostic Unit Public Health Laboratory, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
Surbhi Malhotra-KumarLaboratory of Medical Microbiology, Vaccine & Infectious Disease Institute, Universiteit Antwerpen, Wilrijk, Belgium.
Guido WernerNational Reference Centre for Staphylococci and Enterococci, Division of Nosocomial Pathogens and Antibiotic Resistances, Department of Infectious Diseases, Robert Koch Institute, Wernigerode Branch, Wernigerode, Germany.
Katsunori YanagiharaDepartment of Laboratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Ashlee M EarlInfectious Disease & Microbiome Program, Broad Institute, Cambridge, MA, USA.
Katherine E RavenDepartment of Medicine, University of Cambridge, Cambridge, UK.
Jukka CoranderDepartment of Biostatistics, University of Oslo, Oslo, Norway.
Rory BowdenThe Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, 3052, Australia.
Enterococcal Group
The University of Melbourne · AUBroad Institute · USStatens Serum Institut · DKThe Royal Melbourne Hospital · AUThe University of Sydney · AUUniversity of Antwerp · BECambridge University Hospitals NHS Foundation Trust · GBRobert Koch Institute · DEUniversity Hospital of North Norway · NOUniversity of Oslo · NO

Funding

Viral Genomics: evolution, spread, and host interactionsU19AI110818 · NIAID · BROAD INSTITUTE, INC. · PI CUOMO, CHRISTINA A · 2014 to 2024
$66.5M
NIAID NIH HHS HHSN272200900018CNIAID NIH HHS U19 AI110818Wellcome Trust 203141/Z/16/Z
6 · The paper itself

Abstract

backgroundThe hospital-adapted A1 group of Enterococcus faecium remains an organism of significant concern in the context of drug-resistant hospital-associated infections. How this pathogen evolves and disseminates remains poorly understood.

methodsA large, globally representative collection of short-read genomic data from the hospital-associated A1 group of Enterococcus faecium was assembled (n = 973). We analysed, using a novel analysis approach, global diversity in terms of both the dynamics of the accessory genome and homologous recombination among conserved genes.

resultsTwo main modes of genomic evolution continue to shape E. faecium: the acquisition and loss of genes, including antimicrobial resistance genes, through mobile genetic elements including plasmids, and homologous recombination of the core genome. These events lead to new clones emerging at the local level, followed by the erosion of signals of clonality through recombination, and in some identifiable cases producing new clonal clusters. These patterns lead to new, emerging lineages which are able to spread globally over relatively short timeframes.

conclusionsThe ability of A1 E. faecium to continually present new combinations of genes for potential selection suggests that controlling this pathogen will remain challenging but establishing a framework for understanding genomic evolution is likely to aid in tracking the threats posed by newly emerging lineages.

Indexed as

HospitalsInternationalityAdaptation, PhysiologicalAnti-Bacterial AgentsClone CellsCluster AnalysisEnterococcus faeciumGenome, BacterialMicrobial Sensitivity TestsPlasmidsAnti-Bacterial Agents

Identifiers

PMID33785076
PMCPMC8008517
OpenAlexW3148620156

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.